Abstract:c A S E R E P O R t SAn enteric fistula that occurs in an open abdomen is called an enteroatmospheric fistula (EAF) and is the most challenging complication for a surgical team to deal with. The treatment of EAF requires a multidisciplinary approach. First of all, sepsis has to be managed. Any fluid, electrolyte and metabolic disorders need to be corrected. Oral intake must be stopped and total parenteral nutrition introduced. The control and drainage of the effluent from the fistula is a separate issue. Since… Show more
“…In about half of the cases, different techniques for fistula isolation were used, whereas in the other half of patients, NPWT with/without special fistula patches/plugs were employed for fistula occlusion . Three possible outcomes are described for EAF treatment: spontaneous closure, conditioning of the surrounding wound, and conversion into an ECF with delayed surgical fistula elimination or definite ECF without need for fistula elimination . Furthermore, in 38.5% of the cases, there was spontaneous fistula closure during treatment, with higher probability in low‐output fistulas .…”
Enteroatmospheric fistulas (EAF) are rare but challenging and morbid complications of abdominal surgery and require time- as well as resource-consuming management. Furthermore, they severely affect patients' quality of life. Several treatment modalities for EAF management are described in the literature. We describe 3 consecutive cases of EAF treatment by employing negative pressure wound therapy (NPWT) along with either a special silicone fistula adapter or a Silo-Vac-like system in another case to isolate the fistula from the remaining abdominal wound. Spontaneous fistula closure was achieved in 2 of the 3 cases, and surgical resection of the small bowel segment harbouring EAF opening was possible in a third case after wound conditioning. The rate of fistula closure was 100% (n = 3/3). Compartmentalisation of the contaminated area using NPWT accelerated healing of the open abdominal wound remarkably. In summary, we present a useful tool for the challenging management of EAF and review the literature on different treatment options of EAF available today.
“…In about half of the cases, different techniques for fistula isolation were used, whereas in the other half of patients, NPWT with/without special fistula patches/plugs were employed for fistula occlusion . Three possible outcomes are described for EAF treatment: spontaneous closure, conditioning of the surrounding wound, and conversion into an ECF with delayed surgical fistula elimination or definite ECF without need for fistula elimination . Furthermore, in 38.5% of the cases, there was spontaneous fistula closure during treatment, with higher probability in low‐output fistulas .…”
Enteroatmospheric fistulas (EAF) are rare but challenging and morbid complications of abdominal surgery and require time- as well as resource-consuming management. Furthermore, they severely affect patients' quality of life. Several treatment modalities for EAF management are described in the literature. We describe 3 consecutive cases of EAF treatment by employing negative pressure wound therapy (NPWT) along with either a special silicone fistula adapter or a Silo-Vac-like system in another case to isolate the fistula from the remaining abdominal wound. Spontaneous fistula closure was achieved in 2 of the 3 cases, and surgical resection of the small bowel segment harbouring EAF opening was possible in a third case after wound conditioning. The rate of fistula closure was 100% (n = 3/3). Compartmentalisation of the contaminated area using NPWT accelerated healing of the open abdominal wound remarkably. In summary, we present a useful tool for the challenging management of EAF and review the literature on different treatment options of EAF available today.
“…Whether the use of VSD after abdominal surgery can lead to secondary intestinal injury and increase the incidence of intestinal fistulas is controversial. At present, an increasing number of studies have confirmed that the use of VSD does not increase the incidence of intestinal fistulas 21, 30, 34, 50, 55, 96, 127, 145, 148, 152, 154, 156…”
Section: Recommendationsmentioning
confidence: 95%
“…A total of 22 studies were included, one RCT, 110 one systematic review, 111 and 20 observational studies. 80 , 93 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 …”
Section: Recommendationsmentioning
confidence: 99%
“…At present, an increasing number of studies have confirmed that the use of VSD does not increase the incidence of intestinal fistulas. 21 , 30 , 34 , 50 , 55 , 96 , 127 , 145 , 148 , 152 , 154 , 156 …”
Section: Recommendationsmentioning
confidence: 99%
“…Treatment of an open abdomen with an enteroatmospheric fistula is very tricky. VSD has been reported to have many advantages for the treatment of enteroatmospheric fistulas 93, 127. Regarding the study of isolation techniques for enteroatmospheric fistulas, four observational studies showed that VAC could be combined with a “ring”/“silo”, tire ring, or pacifier method to isolate wounds and intestinal fistulas 80, 123, 124, 125…”
Vacuum sealing drainage (VSD) is frequently used in abdominal surgeries. However, relevant guidelines are rare. Chinese Trauma Surgeon Association organized a committee composed of 28 experts across China in July 2017, aiming to provide an evidence-based recommendation for the application of VSD in abdominal surgeries.
Eleven questions regarding the use of VSD in abdominal surgeries were addressed: (1) which type of materials should be respectively chosen for the intraperitoneal cavity, retroperitoneal cavity and superficial incisions? (2) Can VSD be preventively used for a high-risk abdominal incision with primary suture? (3) Can VSD be used in severely contaminated/infected abdominal surgical sites? (4) Can VSD be used for temporary abdominal cavity closure under some special conditions such as severe abdominal trauma, infection, liver transplantation and intra-abdominal volume increment in abdominal compartment syndrome? (5) Can VSD be used in abdominal organ inflammation, injury, or postoperative drainage? (6) Can VSD be used in the treatment of intestinal fistula and pancreatic fistula? (7) Can VSD be used in the treatment of intra-abdominal and extra-peritoneal abscess? (8) Can VSD be used in the treatment of abdominal wall wounds, wound cavity, and defects? (9) Does VSD increase the risk of bleeding? (10) Does VSD increase the risk of intestinal wall injury? (11) Does VSD increase the risk of peritoneal adhesion?
Focusing on these questions, evidence-based recommendations were given accordingly. VSD was strongly recommended regarding the questions 2–4. Weak recommendations were made regarding questions 1 and 5–11. Proper use of VSD in abdominal surgeries can lower the risk of infection in abdominal incisions with primary suture, treat severely contaminated/infected surgical sites and facilitate temporary abdominal cavity closure.